58 related articles for article (PubMed ID: 11136563)
1. Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009.
Tiersten AD; Liu PY; Smith HO; Wilczynski SP; Robinson WR; Markman M; Alberts DS
Gynecol Oncol; 2009 Mar; 112(3):444-9. PubMed ID: 19138791
[TBL] [Abstract][Full Text] [Related]
2. Outcomes with chemotherapy in carcinoma penis: Experience from a tertiary cancer center.
Mailankody S; Radhakrishnan V; Raja A; Ganesan TS; Dhanushkodi M; Sagar TG
Indian J Cancer; 2023; 60(3):396-402. PubMed ID: 36861700
[TBL] [Abstract][Full Text] [Related]
3. Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience.
Rubinstein M; Halpenny D; Makker V; Grisham RN; Aghajanian C; Cadoo K
Gynecol Oncol Rep; 2019 May; 28():120-123. PubMed ID: 31011610
[TBL] [Abstract][Full Text] [Related]
4. Retrospective study of histopathological and prognostic characteristics of primary fallopian tube carcinomas: twenty-year experience (SOCRATE).
Borghese M; Vizzielli G; Capelli G; Santoro A; Angelico G; Arciuolo D; Biglia N; Ferrero A; Sgro LG; Ponzone R; Scambia G; Fagotti A; Zannoni GF
Int J Gynecol Cancer; 2022 Jul; ():. PubMed ID: 35868656
[TBL] [Abstract][Full Text] [Related]
5. Optimal Strategy and Benefit of Pulsed Therapy Depend On Tumor Heterogeneity and Aggressiveness at Time of Treatment Initiation.
Mathur D; Taylor BP; Chatila WK; Scher HI; Schultz N; Razavi P; Xavier JB
Mol Cancer Ther; 2022 May; 21(5):831-843. PubMed ID: 35247928
[TBL] [Abstract][Full Text] [Related]
6. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.
Berek JS; Renz M; Kehoe S; Kumar L; Friedlander M
Int J Gynaecol Obstet; 2021 Oct; 155 Suppl 1(Suppl 1):61-85. PubMed ID: 34669199
[TBL] [Abstract][Full Text] [Related]
7. Responses of metastatic primary fallopian tube carcinoma to pembrolizumab and nab-paclitaxel: A case report.
Jiang J; Chen ZP; Zhu HP; Zhang YQ; Qian XL; Zhang M; Ni C; Zuo Y
Medicine (Baltimore); 2020 Jul; 99(28):e21203. PubMed ID: 32664168
[TBL] [Abstract][Full Text] [Related]
8. [Not Available].
Mamouni N; Saadi H; Belfatemi H; Erraghay S; Bouchikhi C; Banani A
Pan Afr Med J; 2017; 28():163. PubMed ID: 29541309
[TBL] [Abstract][Full Text] [Related]
9. Primary Adenocarcinoma of the Fallopian Tube: A Rare Entity.
Singh A; Prasad S; Kumar A; Tanwar R
J Clin Diagn Res; 2017 Sep; 11(9):QD03-QD04. PubMed ID: 29207787
[TBL] [Abstract][Full Text] [Related]
10. Primary fallopian tube carcinoma: a case report.
Boufettal H; Samouh N
Pan Afr Med J; 2014; 18():263. PubMed ID: 25426210
[TBL] [Abstract][Full Text] [Related]
11. Primary carcinoma of the fallopian tube: a review of a single institution experience of 8 cases.
Nanaiah SP; Rathod PS; Rajkumar NN; Kundargi R; Subbian A; Ramachandra PV; Krishnappa S; Narayan A; Devi UK; Uttamchand BD
ScientificWorldJournal; 2014; 2014():630731. PubMed ID: 24696653
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic primary fallopian tube cancer: an unusual cause of axillary lymphadenopathy.
Healy NA; Hynes SO; Bruzzi J; Curran S; O'Leary M; Sweeney KJ
Case Rep Obstet Gynecol; 2011; 2011():402127. PubMed ID: 22567506
[TBL] [Abstract][Full Text] [Related]
13. Primary transitional cell carcinoma of the fallopian tube in a premenopausal woman: A case report and review of literature.
Babu MR; Haji AG; Chitrathara K; Vijaykumar DK; Samanta J; Hiran KR
Indian J Med Paediatr Oncol; 2009 Jan; 30(1):35-8. PubMed ID: 20668606
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-based chemotherapy in carcinoma of the fallopian tube.
Gemignani ML; Hensley ML; Cohen R; Venkatraman E; Saigo PE; Barakat RR
Gynecol Oncol; 2001 Jan; 80(1):16-20. PubMed ID: 11136563
[TBL] [Abstract][Full Text] [Related]
15. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
16. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin.
Piver MS; Eltabbakh GH; Hempling RE; Recio FO; Blumenson LE
Gynecol Oncol; 1997 Nov; 67(2):141-6. PubMed ID: 9367697
[TBL] [Abstract][Full Text] [Related]
17. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Morris M; Gershenson DM; Burke TW; Kavanagh JJ; Silva EG; Wharton JT
Obstet Gynecol; 1990 Dec; 76(6):1020-4. PubMed ID: 2234710
[TBL] [Abstract][Full Text] [Related]
18. Second-look laparotomy in carcinoma of the fallopian tube.
Barakat RR; Rubin SC; Saigo PE; Lewis JL; Jones WB; Curtin JP
Obstet Gynecol; 1993 Nov; 82(5):748-51. PubMed ID: 8414320
[TBL] [Abstract][Full Text] [Related]
19. Hepatic resection for metastatic gynecologic carcinomas.
Chi DS; Fong Y; Venkatraman ES; Barakat RR
Gynecol Oncol; 1997 Jul; 66(1):45-51. PubMed ID: 9234920
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
